355 related articles for article (PubMed ID: 18401020)
1. Impaired insulin secretion increases the risk of Alzheimer disease.
Rönnemaa E; Zethelius B; Sundelöf J; Sundström J; Degerman-Gunnarsson M; Berne C; Lannfelt L; Kilander L
Neurology; 2008 Sep; 71(14):1065-71. PubMed ID: 18401020
[TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men.
Rönnemaa E; Zethelius B; Sundelöf J; Sundström J; Degerman-Gunnarsson M; Lannfelt L; Berne C; Kilander L
Diabetologia; 2009 Aug; 52(8):1504-10. PubMed ID: 19455303
[TBL] [Abstract][Full Text] [Related]
3. Serum cystatin C and the risk of Alzheimer disease in elderly men.
Sundelöf J; Arnlöv J; Ingelsson E; Sundström J; Basu S; Zethelius B; Larsson A; Irizarry MC; Giedraitis V; Rönnemaa E; Degerman-Gunnarsson M; Hyman BT; Basun H; Kilander L; Lannfelt L
Neurology; 2008 Sep; 71(14):1072-9. PubMed ID: 18824671
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.
Matsuzaki T; Sasaki K; Tanizaki Y; Hata J; Fujimi K; Matsui Y; Sekita A; Suzuki SO; Kanba S; Kiyohara Y; Iwaki T
Neurology; 2010 Aug; 75(9):764-70. PubMed ID: 20739649
[TBL] [Abstract][Full Text] [Related]
5. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.
Li G; Shofer JB; Kukull WA; Peskind ER; Tsuang DW; Breitner JC; McCormick W; Bowen JD; Teri L; Schellenberg GD; Larson EB
Neurology; 2005 Oct; 65(7):1045-50. PubMed ID: 16217057
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors and glucose tolerance in midlife and risk of cognitive disorders in old age up to a 49-year follow-up of the Helsinki businessmen study.
Rantanen K; Strandberg AY; Salomaa V; Pitkälä K; Tilvis RS; Tienari P; Strandberg T
Ann Med; 2017 Sep; 49(6):462-469. PubMed ID: 28151011
[TBL] [Abstract][Full Text] [Related]
7. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
[TBL] [Abstract][Full Text] [Related]
8. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study.
Schrijvers EM; Witteman JC; Sijbrands EJ; Hofman A; Koudstaal PJ; Breteler MM
Neurology; 2010 Nov; 75(22):1982-7. PubMed ID: 21115952
[TBL] [Abstract][Full Text] [Related]
9. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
[TBL] [Abstract][Full Text] [Related]
10. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.
Diabetes Prevention Program Research Group
Hypertension; 2002 Nov; 40(5):679-86. PubMed ID: 12411462
[TBL] [Abstract][Full Text] [Related]
11. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.
van Himbergen TM; Beiser AS; Ai M; Seshadri S; Otokozawa S; Au R; Thongtang N; Wolf PA; Schaefer EJ
Arch Neurol; 2012 May; 69(5):594-600. PubMed ID: 22213409
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study.
Takkunen MJ; Schwab US; de Mello VD; Eriksson JG; Lindström J; Tuomilehto J; Uusitupa MI;
Eur J Nutr; 2016 Apr; 55(3):967-79. PubMed ID: 25930966
[TBL] [Abstract][Full Text] [Related]
14. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.
Reitz C; den Heijer T; van Duijn C; Hofman A; Breteler MM
Neurology; 2007 Sep; 69(10):998-1005. PubMed ID: 17785668
[TBL] [Abstract][Full Text] [Related]
15. How can elderly apolipoprotein E ε4 carriers remain free from dementia?
Ferrari C; Xu WL; Wang HX; Winblad B; Sorbi S; Qiu C; Fratiglioni L
Neurobiol Aging; 2013 Jan; 34(1):13-21. PubMed ID: 22503000
[TBL] [Abstract][Full Text] [Related]
16. Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin.
Morris JK; Vidoni ED; Mahnken JD; Montgomery RN; Johnson DK; Thyfault JP; Burns JM
Neurobiol Aging; 2016 Mar; 39():19-24. PubMed ID: 26923398
[TBL] [Abstract][Full Text] [Related]
17. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
18. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort.
Rönnemaa E; Zethelius B; Lannfelt L; Kilander L
Dement Geriatr Cogn Disord; 2011; 31(6):460-6. PubMed ID: 21791923
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of vascular risk factors and risk of incident Alzheimer disease.
Luchsinger JA; Reitz C; Honig LS; Tang MX; Shea S; Mayeux R
Neurology; 2005 Aug; 65(4):545-51. PubMed ID: 16116114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
